New Horizons in Type 1 Diabetes Care: Off-Label Use of GLP-1 and SGLT2 Inhibitors

The study can provide useful information to interventional cardiologists performing PCI with new-generation DES in AMI patients, regarding the importance of hyperglycemia (especially prediabetes) and the relationship with worse cardiovascular outcomes after both high intensity and low-moderate-intensity statin treatment